首页 > 最新文献

Drug metabolism and personalized therapy最新文献

英文 中文
Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity 曼陀罗能消除小鼠的抑郁和焦虑样障碍:其抗抑郁活性可能涉及单胺能途径
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-02-24 DOI: 10.1515/dmpt-2021-0166
M. A. Akanji, Oyinloye O. Elijah, Alabi A. Oyedolapo, Aderionla A. Aderonke, Ogunjimi L. Opeoluwa, A. Omoloye, F. Oladoja, S. O. Olatundun, Osipitan L. Edatomolaosi
Abstract Objectives Ethno-botanical surveys uncovered the use of Datura stramonium in the management of mental health abnormalities. Antidepressant- and anxiolytic-like activities of hydroethanol leaf extract of D. stramonium (HLDS) in mice and its possible mechanism of action were investigated in this study. Methods The hole-board test (HBT), open field test (OFT), elevated plus maze test (EPMT), and social interaction test (SIT) were used to investigate the anxiolytic-like activity while forced swim test (FST) and tail suspension test (TST) were employed for the antidepressant effect. Mice were pre-treated orally with purified water (10 mL/kg), bromazepam (1 mg/kg), fluoxetine (20 mg/kg) and D. stramonium (25, 50, 100 and 200 mg/kg). One hour post-treatment, mice were subjected to the various tests. Results In HBT, D. stramonium increased the head dips and sectional crossings turnover. D. stramonium increased the number of square crossed and rearings/assisted rearings in OFT. DS increased the time spent in open arms of EPM. In SIT, D. stramonium increased the frequency/duration of interactions. In FST and TST, D. stramonium decreased the duration of immobility which were reversed by doxazosin (α1 adrenoceptor antagonist) and ondasentron (5-HT3 receptor antagonist). Conclusions HLDS has anxiolytic- and antidepressant-like activities through modulation of serotoninergic and adrenergic neurotransmissions.
目的民族植物学调查揭示曼陀罗在精神健康异常治疗中的应用。本研究探讨了曲曲霉氢乙醇叶提取物(hds)对小鼠的抗抑郁和抗焦虑样活性及其可能的作用机制。方法采用孔板试验(HBT)、开阔场试验(OFT)、升高+迷宫试验(EPMT)和社会互动试验(SIT)考察焦虑样活动,采用强迫游泳试验(FST)和悬尾试验(TST)考察抗抑郁效果。小鼠分别口服纯净水(10 mL/kg)、溴西泮(1 mg/kg)、氟西汀(20 mg/kg)和司曲铵(25、50、100和200 mg/kg)进行预处理。治疗1小时后,小鼠接受各种测试。结果在HBT中,曲曲霉菌增加了头部下陷和截面交叉周转率。曲霉菌增加了OFT中方形杂交和饲养/辅助饲养的数量。DS增加了EPM张开双臂的时间。在SIT中,D. stramonium增加了相互作用的频率/持续时间。在FST和TST中,D. stramonium减少了静止时间,而doxazosin (α1肾上腺素受体拮抗剂)和ondasentron (5-HT3受体拮抗剂)逆转了这一现象。结论hds通过调节血清素能和肾上腺素能神经递质具有抗焦虑和抗抑郁样活性。
{"title":"Datura stramonium abrogates depression- and anxiety-like disorders in mice: possible involvement of monoaminergic pathways in its antidepressant activity","authors":"M. A. Akanji, Oyinloye O. Elijah, Alabi A. Oyedolapo, Aderionla A. Aderonke, Ogunjimi L. Opeoluwa, A. Omoloye, F. Oladoja, S. O. Olatundun, Osipitan L. Edatomolaosi","doi":"10.1515/dmpt-2021-0166","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0166","url":null,"abstract":"Abstract Objectives Ethno-botanical surveys uncovered the use of Datura stramonium in the management of mental health abnormalities. Antidepressant- and anxiolytic-like activities of hydroethanol leaf extract of D. stramonium (HLDS) in mice and its possible mechanism of action were investigated in this study. Methods The hole-board test (HBT), open field test (OFT), elevated plus maze test (EPMT), and social interaction test (SIT) were used to investigate the anxiolytic-like activity while forced swim test (FST) and tail suspension test (TST) were employed for the antidepressant effect. Mice were pre-treated orally with purified water (10 mL/kg), bromazepam (1 mg/kg), fluoxetine (20 mg/kg) and D. stramonium (25, 50, 100 and 200 mg/kg). One hour post-treatment, mice were subjected to the various tests. Results In HBT, D. stramonium increased the head dips and sectional crossings turnover. D. stramonium increased the number of square crossed and rearings/assisted rearings in OFT. DS increased the time spent in open arms of EPM. In SIT, D. stramonium increased the frequency/duration of interactions. In FST and TST, D. stramonium decreased the duration of immobility which were reversed by doxazosin (α1 adrenoceptor antagonist) and ondasentron (5-HT3 receptor antagonist). Conclusions HLDS has anxiolytic- and antidepressant-like activities through modulation of serotoninergic and adrenergic neurotransmissions.","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81021755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
CYP450 2D6 and 2C19 genotypes in ADHD: not related with treatment resistance but with over-representation of 2C19 ultra-metabolizers ADHD患者CYP450 2D6和2C19基因型:与治疗耐药无关,但与2C19超代谢物的过度表达有关
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-02-24 DOI: 10.1515/dmpt-2021-0163
M. Kutuk, A. Tufan, Z. Topal, Ufuk Acikbas, G. Guler, Bahriye Karakaş, H. Basaga, F. Kılıçaslan, E. Altıntaş, Yeliz Aka, O. Kutuk
Abstract Objectives Cytochrome P450 (CYP450) is a major enzyme system involved in drug metabolism as well as regulation of brain function. Although individual variability in CYP enzymes have been studied in terms of personality traits and treatment effects, no study up to now evaluated CYP polymorphisms in children with attention deficit/hyperactivity disorder (ADHD). We aimed to define the genetic profiles of CYP2D6 and CYP2C19 relevant alleles in children with ADHD according to treatment status and compare the frequencies according to past results. Methods Three hundred and seventeen patients with ADHD-Combined Presentation were enrolled; symptom severity was evaluated by parents and clinicians while adverse effects of previous treatments were evaluated with parent and child reports. Reverse blotting on strip assays was used for genotyping and descriptive and bivariate analyses were conducted. A p-value was set at 0.05 (two-tailed). Results Children were divided into treatment-naïve (n=194, 61.2%) and treatment-resistant (n=123, 38.8%) groups. Within the whole sample PM, EM and UM status according to 2D6 were 3.8% (n=12), 94.3% (n=299) and 21.9% (n=6); respectively. PM, IM, EM and UM status according to 2C19 were 2.5% (n=8), 19.8% (n=63), 48.6% (n=154) and 29.0% (n=92), respectively. No relationship with treatment resistance, comorbidity or gender could be found. Importantly, CYP2C19 UMs were significantly more frequent in ADHD patients compared to previous studies in the general population. Conclusions CYPs may be a rewarding avenue of research to elucidate the etiology and treatment of patients with ADHD.
细胞色素P450 (CYP450)是参与药物代谢和脑功能调节的主要酶系统。虽然CYP酶的个体差异已经在人格特征和治疗效果方面进行了研究,但目前还没有研究评估注意缺陷/多动障碍(ADHD)儿童的CYP多态性。我们的目的是根据治疗状况确定ADHD儿童中CYP2D6和CYP2C19相关等位基因的遗传谱,并根据以往的结果比较其频率。方法纳入317例adhd合并表现患者;由家长和临床医生评估症状严重程度,同时根据家长和儿童报告评估既往治疗的不良反应。采用条带反印迹法进行基因分型,并进行描述性和双变量分析。p值设为0.05(双尾)。结果患儿分为treatment-naïve组(n=194, 61.2%)和耐药组(n=123, 38.8%)。在整个样本中,2D6的PM、EM和UM状态分别为3.8% (n=12)、94.3% (n=299)和21.9% (n=6);分别。2C19的PM、IM、EM和UM状态分别为2.5% (n=8)、19.8% (n=63)、48.6% (n=154)和29.0% (n=92)。与治疗耐药、合并症及性别无关系。重要的是,与以往在普通人群中的研究相比,CYP2C19 UMs在ADHD患者中的发生率明显更高。结论CYPs可能是研究ADHD病因和治疗的有益途径。
{"title":"CYP450 2D6 and 2C19 genotypes in ADHD: not related with treatment resistance but with over-representation of 2C19 ultra-metabolizers","authors":"M. Kutuk, A. Tufan, Z. Topal, Ufuk Acikbas, G. Guler, Bahriye Karakaş, H. Basaga, F. Kılıçaslan, E. Altıntaş, Yeliz Aka, O. Kutuk","doi":"10.1515/dmpt-2021-0163","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0163","url":null,"abstract":"Abstract Objectives Cytochrome P450 (CYP450) is a major enzyme system involved in drug metabolism as well as regulation of brain function. Although individual variability in CYP enzymes have been studied in terms of personality traits and treatment effects, no study up to now evaluated CYP polymorphisms in children with attention deficit/hyperactivity disorder (ADHD). We aimed to define the genetic profiles of CYP2D6 and CYP2C19 relevant alleles in children with ADHD according to treatment status and compare the frequencies according to past results. Methods Three hundred and seventeen patients with ADHD-Combined Presentation were enrolled; symptom severity was evaluated by parents and clinicians while adverse effects of previous treatments were evaluated with parent and child reports. Reverse blotting on strip assays was used for genotyping and descriptive and bivariate analyses were conducted. A p-value was set at 0.05 (two-tailed). Results Children were divided into treatment-naïve (n=194, 61.2%) and treatment-resistant (n=123, 38.8%) groups. Within the whole sample PM, EM and UM status according to 2D6 were 3.8% (n=12), 94.3% (n=299) and 21.9% (n=6); respectively. PM, IM, EM and UM status according to 2C19 were 2.5% (n=8), 19.8% (n=63), 48.6% (n=154) and 29.0% (n=92), respectively. No relationship with treatment resistance, comorbidity or gender could be found. Importantly, CYP2C19 UMs were significantly more frequent in ADHD patients compared to previous studies in the general population. Conclusions CYPs may be a rewarding avenue of research to elucidate the etiology and treatment of patients with ADHD.","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90654511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Factors influencing methotrexate and methotrexate polyglutamate in patients with rheumatoid arthritis: a systematic review of population pharmacokinetics 类风湿关节炎患者甲氨蝶呤和甲氨蝶呤聚谷氨酸的影响因素:人群药代动力学的系统综述
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-02-24 DOI: 10.1515/dmpt-2021-0190
Janthima Methaneethorn, Rowan Alejielat, Nattawut Leelakanok
Abstract Low dose methotrexate (MTX) is commonly used in the treatment of rheumatoid arthritis. The clinical effect is mediated by its metabolite, methotrexate polyglutamate (MTX-PGn). The drug exhibits high interindividual pharmacokinetic variability and the optimal MTX dose is different among individuals. Thus, several MTX population pharmacokinetic (PopPK) models were developed to characterize factors affecting MTX pharmacokinetic variability. This review summarizes significant predictors for MTX pharmacokinetics and identifies knowledge gaps to be further examined. A total of 359 articles were identified from a systematic search of four databases: PubMed, Science Direct, and CINAHL Complete. Of these eight studies were included. Most studies investigated influential factors on MTX pharmacokinetics, but information on MTX-PGn is limited, with only one study performing a parent-metabolite (MTX-PG3) model. MTX pharmacokinetics was described using a two-compartment model with first-order elimination in most studies, with the MTX clearance ranging from 6.94 to 12.39 L/h. Significant predictors influencing MTX clearance included weight, creatinine clearance, sex, OATP1B3 polymorphism, and MTX multiple dosing. While body mass index and red blood cell counts were significant predictors for MTX-PG3 clearance. Providing that MTX-PGn plays a crucial role in clinical effect, further studies should determine other factors affecting MTX-PGn as well as its relationship with clinical response.
摘要低剂量甲氨蝶呤(MTX)是治疗类风湿性关节炎的常用药物。临床效果是由其代谢物甲氨蝶呤聚谷氨酸(MTX-PGn)介导的。药物表现出高度的个体间药代动力学变异性,最佳MTX剂量在个体之间是不同的。因此,开发了几个MTX群体药代动力学(PopPK)模型来表征影响MTX药代动力学变异性的因素。这篇综述总结了MTX药代动力学的重要预测因素,并确定了有待进一步研究的知识空白。系统检索PubMed、Science Direct和CINAHL Complete四个数据库,共发现359篇文章。纳入了这8项研究。大多数研究调查了MTX药代动力学的影响因素,但关于MTX- pgn的信息有限,只有一项研究采用了母体代谢物(MTX- pg3)模型。大多数研究采用一阶消除的双室模型描述MTX药代动力学,MTX清除率范围为6.94 ~ 12.39 L/h。影响MTX清除率的重要预测因素包括体重、肌酐清除率、性别、OATP1B3多态性和MTX多次给药。而体重指数和红细胞计数是MTX-PG3清除率的重要预测因子。鉴于MTX-PGn在临床疗效中起着至关重要的作用,进一步的研究应确定影响MTX-PGn的其他因素及其与临床反应的关系。
{"title":"Factors influencing methotrexate and methotrexate polyglutamate in patients with rheumatoid arthritis: a systematic review of population pharmacokinetics","authors":"Janthima Methaneethorn, Rowan Alejielat, Nattawut Leelakanok","doi":"10.1515/dmpt-2021-0190","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0190","url":null,"abstract":"Abstract Low dose methotrexate (MTX) is commonly used in the treatment of rheumatoid arthritis. The clinical effect is mediated by its metabolite, methotrexate polyglutamate (MTX-PGn). The drug exhibits high interindividual pharmacokinetic variability and the optimal MTX dose is different among individuals. Thus, several MTX population pharmacokinetic (PopPK) models were developed to characterize factors affecting MTX pharmacokinetic variability. This review summarizes significant predictors for MTX pharmacokinetics and identifies knowledge gaps to be further examined. A total of 359 articles were identified from a systematic search of four databases: PubMed, Science Direct, and CINAHL Complete. Of these eight studies were included. Most studies investigated influential factors on MTX pharmacokinetics, but information on MTX-PGn is limited, with only one study performing a parent-metabolite (MTX-PG3) model. MTX pharmacokinetics was described using a two-compartment model with first-order elimination in most studies, with the MTX clearance ranging from 6.94 to 12.39 L/h. Significant predictors influencing MTX clearance included weight, creatinine clearance, sex, OATP1B3 polymorphism, and MTX multiple dosing. While body mass index and red blood cell counts were significant predictors for MTX-PG3 clearance. Providing that MTX-PGn plays a crucial role in clinical effect, further studies should determine other factors affecting MTX-PGn as well as its relationship with clinical response.","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83594337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the stability of furosemide in tablet form during six-month storage in spaceflight and peculiarities of its pharmacokinetics and pharmacodynamics under conditions of anti-orthostatic hypokinesia 航天飞行6个月贮存期速尿片剂稳定性评价及抗直立性运动障碍条件下药代动力学和药效学特点
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2022-02-24 DOI: 10.1515/dmpt-2021-0149
A. V. Polyakov, Andreу A. Svistunov, S. Kondratenko, I. Kovachevich, Lyudmila G. Repenkovа, Marina I. Savelyevа, E. Shikh, V. Noskov
Abstract Objectives The present study investigated the stability of furosemide under space-flight conditions on board the International Space Station, as well as its pharmacokinetics and pharmacodynamics under conditions simulating exposure to some space-flight factors. Methods Quantitative analysis of furosemide tablets by HPLC was performed before spaceflight (background), then after six months storage under normal ground conditions (control) and under spaceflight conditions (SF). The pharmacokinetics and pharmacodynamics of furosemide were studied in six healthy volunteers after a single oral dose of 40 mg under normal conditions (background) and under anti-orthostatic hypokinesia (ANOH). Results Quantitative content of furosemide in tablets before SF was 40.19 ± 0.28 mg (100.47 ± 0.71%), after 6 months storage: under normal conditions (control) – 39.9 ± 0.39 mg (99.73 ± 0.98%), under SF – 39.24 ± 0.72 mg (98.11 ± 1.80%), which was within the prescribed limits. Studying basic hemodynamic parameters showed that in ANOH conditions 6 h after furosemide administration there was a statistically significant increase of the stroke volume (SV) (+36.5 Δ%), a tendency for increasing of the stroke index (SI) (+36.5 Δ%) and decreasing of the total peripheral resistance (TPR) (−21.9 Δ%) compared to baseline study. Conclusions It has been established that various factors of space flight (overloading, excessive vibration, microgravity, etc.) do not negatively influence the stability of furosemide in tablet form during storage for 6 months on board the International Space Station.
摘要目的研究速尿在国际空间站空间飞行条件下的稳定性,以及模拟暴露于某些空间飞行因素条件下的药代动力学和药效学。方法在航天前(背景)、常规地面条件下(对照)和航天条件下(SF)贮存6个月后,采用高效液相色谱法对呋塞米片进行定量分析。研究了6名健康志愿者在正常(背景)和抗直立性运动减退(ANOH)条件下单次口服呋塞米40mg的药代动力学和药效学。结果顺丰前片中呋塞米的定量含量为40.19±0.28 mg(100.47±0.71%),贮存6个月后:正常条件下(对照)为39.9±0.39 mg(99.73±0.98%),顺丰条件下为39.24±0.72 mg(98.11±1.80%),均在规定限量范围内。研究基本血流动力学参数显示,与基线研究相比,在ANOH条件下,速尿给药后6 h,卒中容积(SV)增加(+ 36.5% Δ%),卒中指数(SI)增加(+ 36.5% Δ%),总外周阻力(TPR)下降(- 21.9 Δ%),具有统计学意义。结论航天飞行的各种因素(超载、过度振动、微重力等)对速尿片剂在国际空间站6个月贮存期间的稳定性没有负面影响。
{"title":"Evaluation of the stability of furosemide in tablet form during six-month storage in spaceflight and peculiarities of its pharmacokinetics and pharmacodynamics under conditions of anti-orthostatic hypokinesia","authors":"A. V. Polyakov, Andreу A. Svistunov, S. Kondratenko, I. Kovachevich, Lyudmila G. Repenkovа, Marina I. Savelyevа, E. Shikh, V. Noskov","doi":"10.1515/dmpt-2021-0149","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0149","url":null,"abstract":"Abstract Objectives The present study investigated the stability of furosemide under space-flight conditions on board the International Space Station, as well as its pharmacokinetics and pharmacodynamics under conditions simulating exposure to some space-flight factors. Methods Quantitative analysis of furosemide tablets by HPLC was performed before spaceflight (background), then after six months storage under normal ground conditions (control) and under spaceflight conditions (SF). The pharmacokinetics and pharmacodynamics of furosemide were studied in six healthy volunteers after a single oral dose of 40 mg under normal conditions (background) and under anti-orthostatic hypokinesia (ANOH). Results Quantitative content of furosemide in tablets before SF was 40.19 ± 0.28 mg (100.47 ± 0.71%), after 6 months storage: under normal conditions (control) – 39.9 ± 0.39 mg (99.73 ± 0.98%), under SF – 39.24 ± 0.72 mg (98.11 ± 1.80%), which was within the prescribed limits. Studying basic hemodynamic parameters showed that in ANOH conditions 6 h after furosemide administration there was a statistically significant increase of the stroke volume (SV) (+36.5 Δ%), a tendency for increasing of the stroke index (SI) (+36.5 Δ%) and decreasing of the total peripheral resistance (TPR) (−21.9 Δ%) compared to baseline study. Conclusions It has been established that various factors of space flight (overloading, excessive vibration, microgravity, etc.) do not negatively influence the stability of furosemide in tablet form during storage for 6 months on board the International Space Station.","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85326075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cnestis ferruginea Vahl ex DC (Connaraceae) downregulates expression of immediate early genes in kainic acid-induced temporal lobe epilepsy in mice. conaraceae植物Cnestis ferruginea Vahl ex DC下调kainic酸诱导小鼠颞叶癫痫的直接早期基因表达。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-09 DOI: 10.1515/dmpt-2021-0145
Emmanuel S Ojo, Ismail O Ishola, Olasunmbo Afolayan, Ayorinde B James, Benneth Ben-Azu, Olufunmilayo O Adeyemi

Objectives: This study investigates the influence of Cnestis ferruginea (CF) on kainic acid (KA)-induced immediate early genes (IEGs) associated with hippocampal sclerosis in temporal lobe epilepsy (TLE) in mice.

Methods: Animals were randomly divided into preventive treatment; vehicle (10 mL/kg, p.o.) or CF (400 mg/kg, p.o.) for three consecutive days before KA (5 mg/kg, i.p.) on days 4 and 5. In the reversal model, KA (5 mg/kg, i.p.) was administered on days 1 and 2 before CF (400 mg/kg) administration on days 3-5. Animals were euthanized on day 5, 6 h after KA exposure in preventive model and 1 h after CF administration in reversal model to estimate markers of IEGs.

Results: KA upregulated the expression of c-Fos protein by 3.32-, 9.45-, 8.13-, and 8.66-fold in the hippocampal CA1, CA2, CA3, and DG regions, respectively. Also, KA elevated inducible nitric oxide synthase protein expression by 10.9-, 10.6-, 9.78-, and 9.51-fold. Besides, mRNA expression of brain-derived neurotrophic factors and heat shock protein was increased by 2.38- and 1.39-fold, respectively, after exposure to KA which were attenuated by CF.

Conclusions: CF attenuated KA-induced IEGs and could be used as an adjunct in TLE.

目的:研究铁酸钠(Cnestis ferruginea, CF)对凯因酸(KA)诱导的颞叶癫痫(TLE)小鼠海马硬化相关早期基因(eggs)的影响。方法:动物随机分为预防组;在第4天和第5天KA (5 mg/kg, i.p.)之前,连续3天服用药液(10 mL/kg, p.o.)或CF (400 mg/kg, p.o.)。在逆转模型中,在第1天和第2天给药KA (5 mg/kg, i.p),第3-5天给药CF (400 mg/kg)。预防模型在KA暴露后第5天、第6小时实施安乐死,逆转模型在给予CF后第1小时实施安乐死,以评估脑电图标志物。结果:KA使海马CA1、CA2、CA3和DG区c-Fos蛋白的表达分别上调3.32-、9.45-、8.13-和8.66倍。此外,KA将诱导型一氧化氮合酶蛋白的表达分别提高了10.9倍、10.6倍、9.78倍和9.51倍。此外,经KA处理后,脑源性神经营养因子和热休克蛋白的mRNA表达分别增加了2.38倍和1.39倍。结论:CF可减弱KA诱导的脑电图,可作为TLE的辅助药物。
{"title":"<i>Cnestis ferruginea</i> Vahl ex DC (Connaraceae) downregulates expression of immediate early genes in kainic acid-induced temporal lobe epilepsy in mice.","authors":"Emmanuel S Ojo,&nbsp;Ismail O Ishola,&nbsp;Olasunmbo Afolayan,&nbsp;Ayorinde B James,&nbsp;Benneth Ben-Azu,&nbsp;Olufunmilayo O Adeyemi","doi":"10.1515/dmpt-2021-0145","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0145","url":null,"abstract":"<p><strong>Objectives: </strong>This study investigates the influence of <i>Cnestis ferruginea</i> (CF) on kainic acid (KA)-induced immediate early genes (IEGs) associated with hippocampal sclerosis in temporal lobe epilepsy (TLE) in mice.</p><p><strong>Methods: </strong>Animals were randomly divided into preventive treatment; vehicle (10 mL/kg, p.o.) or CF (400 mg/kg, p.o.) for three consecutive days before KA (5 mg/kg, i.p.) on days 4 and 5. In the reversal model, KA (5 mg/kg, i.p.) was administered on days 1 and 2 before CF (400 mg/kg) administration on days 3-5. Animals were euthanized on day 5, 6 h after KA exposure in preventive model and 1 h after CF administration in reversal model to estimate markers of IEGs.</p><p><strong>Results: </strong>KA upregulated the expression of c-Fos protein by 3.32-, 9.45-, 8.13-, and 8.66-fold in the hippocampal CA1, CA2, CA3, and DG regions, respectively. Also, KA elevated inducible nitric oxide synthase protein expression by 10.9-, 10.6-, 9.78-, and 9.51-fold. Besides, mRNA expression of brain-derived neurotrophic factors and heat shock protein was increased by 2.38- and 1.39-fold, respectively, after exposure to KA which were attenuated by CF.</p><p><strong>Conclusions: </strong>CF attenuated KA-induced IEGs and could be used as an adjunct in TLE.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39958626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Virgin coconut oil abrogates depression-associated cognitive deficits by modulating hippocampal antioxidant balance, GABAergic and glutamatergic receptors in mice. 初榨椰子油通过调节小鼠海马抗氧化平衡、gaba能和谷氨酸能受体来消除抑郁症相关的认知缺陷。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-09 DOI: 10.1515/dmpt-2021-0126
Edem Ekpenyong Edem, Blessing Eghosa Ihaza, Adedamola Adediran Fafure, Azeez Olakunle Ishola, Kate Eberechukwu Nebo, Linus Anderson Enye, Elizabeth Toyin Akinluyi

Objectives: GABA and glutamate neurotransmission play critical roles in both the neurobiology of depression and cognition; and Virgin coconut oil (VCO) is reported to support brain health. The present study investigated the effect of VCO on depression-associated cognitive deficits in mice.

Methods: Thirty male mice divided into five groups were either exposed to chronic unpredicted mild stress (CUMS) protocol for 28 days or pre-treated with 3 mL/kg b. wt. of VCO for 21 days or post-treated with 3 mL/kg b. wt. of VCO for 21 days following 28 days of CUMS exposure. Mice were subjected to behavioural assessments for depressive-like behaviours and short-term memory, and thereafter euthanised. Hippocampal tissue was dissected from the harvested whole brain for biochemical and immunohistochemical evaluations.

Results: Our results showed that CUMS exposure produced depressive-like behaviours, cognitive deficits and altered hippocampal redox balance. However, treatment with VCO abrogated depression-associated cognitive impairment, and enhanced hippocampal antioxidant concentration. Furthermore, immunohistochemical evaluation revealed significant improvement in GABAA and mGluR1a immunoreactivity following treatment with VCO in the depressed mice.

Conclusions: Therefore, findings from this study support the dietary application of VCO to enhance neural resilience in patients with depression and related disorders.

目的:GABA和谷氨酸神经传递在抑郁症和认知的神经生物学中发挥重要作用;据报道,初榨椰子油(VCO)有助于大脑健康。本研究探讨了VCO对小鼠抑郁相关认知缺陷的影响。方法:30只雄性小鼠分为5组,分别暴露于慢性不可预测轻度应激(CUMS)方案28天,或预处理3 mL/kg b. wt VCO 21天,或在CUMS暴露28天后,后处理3 mL/kg b. wt VCO 21天。研究人员对老鼠进行了类似抑郁的行为和短期记忆的行为评估,然后对它们实施了安乐死。从收获的全脑中解剖海马组织进行生化和免疫组织化学评估。结果:我们的研究结果显示,CUMS暴露会产生抑郁样行为、认知缺陷和海马氧化还原平衡的改变。然而,VCO治疗消除了抑郁症相关的认知障碍,并提高了海马抗氧化剂浓度。此外,免疫组织化学评估显示,在VCO治疗后,抑郁症小鼠的GABAA和mGluR1a免疫反应性显著改善。结论:本研究结果支持VCO在抑郁症及相关疾病患者的饮食应用中增强神经恢复能力。
{"title":"Virgin coconut oil abrogates depression-associated cognitive deficits by modulating hippocampal antioxidant balance, GABAergic and glutamatergic receptors in mice.","authors":"Edem Ekpenyong Edem,&nbsp;Blessing Eghosa Ihaza,&nbsp;Adedamola Adediran Fafure,&nbsp;Azeez Olakunle Ishola,&nbsp;Kate Eberechukwu Nebo,&nbsp;Linus Anderson Enye,&nbsp;Elizabeth Toyin Akinluyi","doi":"10.1515/dmpt-2021-0126","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0126","url":null,"abstract":"<p><strong>Objectives: </strong>GABA and glutamate neurotransmission play critical roles in both the neurobiology of depression and cognition; and Virgin coconut oil (VCO) is reported to support brain health. The present study investigated the effect of VCO on depression-associated cognitive deficits in mice.</p><p><strong>Methods: </strong>Thirty male mice divided into five groups were either exposed to chronic unpredicted mild stress (CUMS) protocol for 28 days or pre-treated with 3 mL/kg <i>b. wt.</i> of VCO for 21 days or post-treated with 3 mL/kg <i>b. wt.</i> of VCO for 21 days following 28 days of CUMS exposure. Mice were subjected to behavioural assessments for depressive-like behaviours and short-term memory, and thereafter euthanised. Hippocampal tissue was dissected from the harvested whole brain for biochemical and immunohistochemical evaluations.</p><p><strong>Results: </strong>Our results showed that CUMS exposure produced depressive-like behaviours, cognitive deficits and altered hippocampal redox balance. However, treatment with VCO abrogated depression-associated cognitive impairment, and enhanced hippocampal antioxidant concentration. Furthermore, immunohistochemical evaluation revealed significant improvement in GABA<sub>A</sub> and mGluR1a immunoreactivity following treatment with VCO in the depressed mice.</p><p><strong>Conclusions: </strong>Therefore, findings from this study support the dietary application of VCO to enhance neural resilience in patients with depression and related disorders.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39704836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Modifying effects of TNF-α, IL-6 and VDR genes on the development risk and the course of COVID-19. Pilot study. TNF-α、IL-6和VDR基因对COVID-19发生风险和病程的调节作用试点研究。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-06 DOI: 10.1515/dmpt-2021-0127
Liliia Fishchuk, Zoia Rossokha, Valeriy Pokhylko, Yuliia Cherniavska, Svitlana Tsvirenko, Serhii Kovtun, Nataliia Medvedieva, Viktoriia Vershyhora, Nataliia Gorovenko

Objectives: COVID-19 continues to range around the world and set morbidity and mortality antirecords. Determining the role of genetic factors in the development of COVID-19 may contribute to the understanding of the pathogenetic mechanisms that lead to the development of complications and fatalities in this disease. The aim of our study was to analyze the effect of TNF-α (rs1800629), IL-6 (rs1800795) and VDR (rs731236 and rs1544410) genes variants on the development risk and the course of COVID-19 in intensive care patients.

Methods: The study group included 31 patients with diagnosis "viral COVID-19 pneumonia". All patients underwent standard daily repeated clinical, instrumental and laboratory examinations. Determination of IL-6, TNF-α, and VDR genes variants was performed using the PCR-RFLP method.

Results: It was found a significant increase in the rate of the CC genotype and C allele (38.7 vs. 12.0% and 0.6 vs. 0.4%, respectively) of the IL-6 gene in all patients of the study in comparison with population frequencies. There was a significantly higher rate of heterozygous genotypes TC and GA of the VDR gene in group of died patients. The rs1800629 variant of the TNF-α gene is associated with the need for respiratory support and its longer duration in patients with COVID-19.

Conclusions: The obtained results support a hypothesis about the influence of variants of IL-6, TNF-α and VDR genes on severity of COVID-19. However, in order to draw definite conclusions, further multifaceted research in this area are need.

目标:2019冠状病毒病继续在世界各地蔓延,并创造了发病率和死亡率反记录。确定遗传因素在COVID-19发展中的作用可能有助于了解导致该疾病并发症和死亡的发病机制。本研究旨在分析TNF-α (rs1800629)、IL-6 (rs1800795)和VDR (rs731236和rs1544410)基因变异对重症监护患者COVID-19发展风险和病程的影响。方法:研究组纳入31例诊断为“病毒性COVID-19肺炎”的患者。所有患者均接受标准的每日重复临床、仪器和实验室检查。采用PCR-RFLP法检测IL-6、TNF-α和VDR基因变异。结果:与人群频率相比,研究中所有患者IL-6基因CC基因型和C等位基因的发生率显著增加(分别为38.7比12.0%和0.6比0.4%)。死亡患者组VDR基因的TC和GA基因型杂合率显著增高。TNF-α基因rs1800629变异与COVID-19患者对呼吸支持的需求及其持续时间延长有关。结论:本研究结果支持IL-6、TNF-α和VDR基因变异对COVID-19严重程度影响的假设。然而,为了得出明确的结论,需要在这一领域进一步进行多方面的研究。
{"title":"Modifying effects of <i>TNF-α</i>, <i>IL-6</i> and <i>VDR</i> genes on the development risk and the course of COVID-19. Pilot study.","authors":"Liliia Fishchuk,&nbsp;Zoia Rossokha,&nbsp;Valeriy Pokhylko,&nbsp;Yuliia Cherniavska,&nbsp;Svitlana Tsvirenko,&nbsp;Serhii Kovtun,&nbsp;Nataliia Medvedieva,&nbsp;Viktoriia Vershyhora,&nbsp;Nataliia Gorovenko","doi":"10.1515/dmpt-2021-0127","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0127","url":null,"abstract":"<p><strong>Objectives: </strong>COVID-19 continues to range around the world and set morbidity and mortality antirecords. Determining the role of genetic factors in the development of COVID-19 may contribute to the understanding of the pathogenetic mechanisms that lead to the development of complications and fatalities in this disease. The aim of our study was to analyze the effect of <i>TNF-α</i> (rs1800629), <i>IL-6</i> (rs1800795) and <i>VDR</i> (rs731236 and rs1544410) genes variants on the development risk and the course of COVID-19 in intensive care patients.</p><p><strong>Methods: </strong>The study group included 31 patients with diagnosis \"viral COVID-19 pneumonia\". All patients underwent standard daily repeated clinical, instrumental and laboratory examinations. Determination of <i>IL-6</i>, <i>TNF-α</i>, and <i>VDR</i> genes variants was performed using the PCR-RFLP method.</p><p><strong>Results: </strong>It was found a significant increase in the rate of the CC genotype and C allele (38.7 vs. 12.0% and 0.6 vs. 0.4%, respectively) of the <i>IL-6</i> gene in all patients of the study in comparison with population frequencies. There was a significantly higher rate of heterozygous genotypes TC and GA of the <i>VDR</i> gene in group of died patients. The rs1800629 variant of the <i>TNF-α</i> gene is associated with the need for respiratory support and its longer duration in patients with COVID-19.</p><p><strong>Conclusions: </strong>The obtained results support a hypothesis about the influence of variants of <i>IL-6</i>, <i>TNF-α</i> and <i>VDR</i> genes on severity of COVID-19. However, in order to draw definite conclusions, further multifaceted research in this area are need.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39941612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Predicting drug-drug interactions by electrochemically driven cytochrome P450 3A4 reactions. 通过电化学驱动细胞色素P450 3A4反应预测药物-药物相互作用。
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-06 eCollection Date: 2022-09-01 DOI: 10.1515/dmpt-2021-0116
Victoria V Shumyantseva, Polina I Koroleva, Tatiana V Bulko, Gennady V Sergeev, Sergei A Usanov

Objectives: Human cytochrome P450 3A4 is the most abundant hepatic and intestinal Phase I enzyme that metabolizes approximately 60% marketed drugs. Simultaneous administration of several drugs may result in appearance of drug-drug interaction. Due to the great interest in the combination therapy, the exploration of the role of drug as "perpetrator" or "victim" is important task in pharmacology. In this work the model systems based on electrochemically driven cytochrome P450 3A4 for the analysis of drug combinations was used. We have shown that the analysis of electrochemical parameters of cytochrome P450 3A4 and especially, potential of the start of catalysis, Eonset, possess predictive properties in the determination of the leading ("perpetrator") properties of drug. Based on these experimental data, we concluded, that the more positive potential of the start of catalysis, Eonset, the more pronounced the role of drug as leading medication.

Methods: Electrochemically driven cytochrome P450 3A4 was used as probe and measuring tool for the estimation of the role of interacting drugs.

Results: It is shown that the electrochemical non-invasive model systems for monitoring the catalytic activity of cytochrome P450 3A4 can be used as prognostic devise in assessment of drug/drug interacting medications.

Conclusions: Cytochrome P450 3A4 activity was studied in electrochemically driven system. Method was implemented to monitor drug/drug interactions. Based on the obtained experimental data, we can conclude that electrochemical parameter such as potential of onset of catalysis, Eonset, has predictive efficiency in assessment of drug/drug interacting medications in the case of the co-administration.

目的:人类细胞色素P450 3A4是最丰富的肝脏和肠道I期酶,代谢约60%的上市药物。同时使用多种药物可能会导致药物相互作用的出现。由于人们对联合治疗的极大兴趣,探索药物作为“加害者”或“受害者”的作用是药理学的重要任务。在这项工作中,基于电化学驱动细胞色素P450 3A4的模型系统用于药物组合分析。我们已经证明,分析细胞色素P450 3A4的电化学参数,特别是催化开始电位,Eonset,在确定药物的主要(“犯罪者”)性质方面具有预测性。基于这些实验数据,我们得出的结论是,催化开始的电位越高,药物作为先导药物的作用就越明显。方法:采用电化学驱动细胞色素P450 3A4作为探针和测量工具,评估相互作用药物的作用。结果:电化学无创模型系统监测细胞色素P450 3A4的催化活性,可作为药物/药物相互作用药物评估的预后工具。结论:在电化学驱动系统中研究了细胞色素P450 3A4的活性。方法用于监测药物/药物相互作用。根据得到的实验数据,我们可以得出电化学参数如催化起始电位Eonset在共给药情况下对药物/药物相互作用药物的评估具有预测效率。
{"title":"Predicting drug-drug interactions by electrochemically driven cytochrome P450 3A4 reactions.","authors":"Victoria V Shumyantseva,&nbsp;Polina I Koroleva,&nbsp;Tatiana V Bulko,&nbsp;Gennady V Sergeev,&nbsp;Sergei A Usanov","doi":"10.1515/dmpt-2021-0116","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0116","url":null,"abstract":"<p><strong>Objectives: </strong>Human cytochrome P450 3A4 is the most abundant hepatic and intestinal Phase I enzyme that metabolizes approximately 60% marketed drugs. Simultaneous administration of several drugs may result in appearance of drug-drug interaction. Due to the great interest in the combination therapy, the exploration of the role of drug as \"perpetrator\" or \"victim\" is important task in pharmacology. In this work the model systems based on electrochemically driven cytochrome P450 3A4 for the analysis of drug combinations was used. We have shown that the analysis of electrochemical parameters of cytochrome P450 3A4 and especially, potential of the start of catalysis, Eonset, possess predictive properties in the determination of the leading (\"perpetrator\") properties of drug. Based on these experimental data, we concluded, that the more positive potential of the start of catalysis, Eonset, the more pronounced the role of drug as leading medication.</p><p><strong>Methods: </strong>Electrochemically driven cytochrome P450 3A4 was used as probe and measuring tool for the estimation of the role of interacting drugs.</p><p><strong>Results: </strong>It is shown that the electrochemical non-invasive model systems for monitoring the catalytic activity of cytochrome P450 3A4 can be used as prognostic devise in assessment of drug/drug interacting medications.</p><p><strong>Conclusions: </strong>Cytochrome P450 3A4 activity was studied in electrochemically driven system. Method was implemented to monitor drug/drug interactions. Based on the obtained experimental data, we can conclude that electrochemical parameter such as potential of onset of catalysis, Eonset, has predictive efficiency in assessment of drug/drug interacting medications in the case of the co-administration.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39941613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Prevalence of ABCB1 3435C>T polymorphism in the Cuban population. ABCB1 3435C>T多态性在古巴人群中的流行
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-06 DOI: 10.1515/dmpt-2020-0156
Idania Rodeiro Guerra, Jose Herrea, Elizabeth Cuétara, Gabino Garrido, Elizabeth Reyes, Ioanna Martínez, Carlos L Pérez, Gisselle Fernández, Ivones Hernández-Balmaseda, René Delgado, Julia C Stingl, Wim Vanden Berghe

Objectives: ABCB1 gene polymorphisms can modify P-glycoprotein function with clinical consequences.

Methods: The 3435C>T polymorphism prevalence was analyzed using oligonucleotide probes and next-generation sequencing in 421 unrelated healthy individuals living in Cuba. Data were stratified by gender, ethnic background and residence. The genotype and allelic frequencies were determined.

Results: The genotype distribution met the Hardy-Weinberg equilibrium assumption. The allelic frequency was 63.5% for the 3435C variant. The genotype frequencies were 41.1% for CC, 44.9% for CT and 14.0% for TT. The allele and genotype distributions differed between individuals living in La Habana and Santiago de Cuba (p<0.05) when ethnic background was analyzed. The allelic distribution was similar among Admixed and Black subjects, and they differed from Caucasians. The CC genotype was equally distributed among Admixed and Black subjects, and they differed from Caucasians. The TT genotype frequency differed between Caucasians and Admixed. The CT genotype was distributed differently among the three groups. Similar distribution was obtained in Brazilians, whereas some similarities were observed in African, Spanish and Chinese populations, consistent with the mixed Cuban ethnic origin.

Conclusions: This is the first report on allele and genotype frequencies of the 3435C>T polymorphism in Cuba, which may support personalized medicine programs.

目的:ABCB1基因多态性可改变p -糖蛋白功能并产生临床后果。方法:采用寡核苷酸探针和新一代测序技术,分析421例古巴无亲缘关系健康人群3435C>T多态性的流行情况。数据按性别、种族背景和居住地分层。测定基因型和等位基因频率。结果:基因型分布符合Hardy-Weinberg平衡假设。3435C变异的等位基因频率为63.5%。CC基因型频率为41.1%,CT为44.9%,TT为14.0%。结论:本文首次报道了古巴3435C>T多态性的等位基因和基因型频率,为个性化医疗方案提供了依据。
{"title":"Prevalence of ABCB1 3435C>T polymorphism in the Cuban population.","authors":"Idania Rodeiro Guerra,&nbsp;Jose Herrea,&nbsp;Elizabeth Cuétara,&nbsp;Gabino Garrido,&nbsp;Elizabeth Reyes,&nbsp;Ioanna Martínez,&nbsp;Carlos L Pérez,&nbsp;Gisselle Fernández,&nbsp;Ivones Hernández-Balmaseda,&nbsp;René Delgado,&nbsp;Julia C Stingl,&nbsp;Wim Vanden Berghe","doi":"10.1515/dmpt-2020-0156","DOIUrl":"https://doi.org/10.1515/dmpt-2020-0156","url":null,"abstract":"<p><strong>Objectives: </strong><i>ABCB1</i> gene polymorphisms can modify P-glycoprotein function with clinical consequences.</p><p><strong>Methods: </strong>The 3435C>T polymorphism prevalence was analyzed using oligonucleotide probes and next-generation sequencing in 421 unrelated healthy individuals living in Cuba. Data were stratified by gender, ethnic background and residence. The genotype and allelic frequencies were determined.</p><p><strong>Results: </strong>The genotype distribution met the Hardy-Weinberg equilibrium assumption. The allelic frequency was 63.5% for the 3435C variant. The genotype frequencies were 41.1% for CC, 44.9% for CT and 14.0% for TT. The allele and genotype distributions differed between individuals living in La Habana and Santiago de Cuba (p<0.05) when ethnic background was analyzed. The allelic distribution was similar among Admixed and Black subjects, and they differed from Caucasians. The CC genotype was equally distributed among Admixed and Black subjects, and they differed from Caucasians. The TT genotype frequency differed between Caucasians and Admixed. The CT genotype was distributed differently among the three groups. Similar distribution was obtained in Brazilians, whereas some similarities were observed in African, Spanish and Chinese populations, consistent with the mixed Cuban ethnic origin.</p><p><strong>Conclusions: </strong>This is the first report on allele and genotype frequencies of the 3435C>T polymorphism in Cuba, which may support personalized medicine programs.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39941611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetic polymorphisms of reproductive hormones and their receptors in assisted reproduction technology for patients with polycystic ovary syndrome. 多囊卵巢综合征患者辅助生殖技术中生殖激素及其受体的遗传多态性
Q2 Pharmacology, Toxicology and Pharmaceutics Pub Date : 2021-12-01 DOI: 10.1515/dmpt-2021-0123
Yulia A Koloda, Yulia V Denisova, Natalia M Podzolkova

Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in women of childbearing, which is defined by the accumulation of multiple, small fluid-filled ovarian cysts without the selection of a single dominant follicle. Most PCOS phenotypes are characterized by the absence of spontaneous ovulation, resistance toward ovulation inductors, the production of a large immature oocytes number, and the high prevalence of ovarian hyperstimulation syndrome, resulting in reduced assisted reproductive technologies (ART) programs effectiveness. The review analyses current data about the relationship between polymorphism genotypes of KISS genes, follicle stimulating hormone (FSH), luteinizing hormone (LH), anti-Müllerian hormone (AMH) and their receptors genes, gonadotropin-releasing hormone (GnRH), estrogen, and progesterone receptors genes, the PCOS risk and the features of ovarian response to stimulation during ART cycles. The use of single nucleotide polymorphisms (SNPs) as prognostic markers of ART programs outcomes would provide a personalized approach to the drugs and doses choice for ovarian stimulation and significantly increase the chance of pregnancy.

多囊卵巢综合征(PCOS)是育龄妇女最常见的内分泌疾病之一,它是由多个充满液体的小卵巢囊肿积聚而没有选择单一的显性卵泡所定义的。大多数PCOS表型的特征是缺乏自发排卵,对排卵诱导剂产生抗性,产生大量未成熟卵母细胞,以及卵巢过度刺激综合征的高发,导致辅助生殖技术(ART)计划的有效性降低。本文分析了促卵泡激素(FSH)、黄体生成素(LH)、抗勒氏激素(AMH)及其受体基因、促性腺激素释放激素(GnRH)、雌激素和孕激素受体基因多态性基因型与抗逆转录病毒治疗周期中卵巢对刺激的反应特征及PCOS风险的关系。使用单核苷酸多态性(snp)作为ART项目结果的预后标记,将为卵巢刺激的药物和剂量选择提供个性化的方法,并显着增加怀孕的机会。
{"title":"Genetic polymorphisms of reproductive hormones and their receptors in assisted reproduction technology for patients with polycystic ovary syndrome.","authors":"Yulia A Koloda,&nbsp;Yulia V Denisova,&nbsp;Natalia M Podzolkova","doi":"10.1515/dmpt-2021-0123","DOIUrl":"https://doi.org/10.1515/dmpt-2021-0123","url":null,"abstract":"<p><p>Polycystic ovary syndrome (PCOS) is one of the most common endocrinopathies in women of childbearing, which is defined by the accumulation of multiple, small fluid-filled ovarian cysts without the selection of a single dominant follicle. Most PCOS phenotypes are characterized by the absence of spontaneous ovulation, resistance toward ovulation inductors, the production of a large immature oocytes number, and the high prevalence of ovarian hyperstimulation syndrome, resulting in reduced assisted reproductive technologies (ART) programs effectiveness. The review analyses current data about the relationship between polymorphism genotypes of <i>KISS</i> genes, follicle stimulating hormone (<i>FSH)</i>, luteinizing hormone (<i>LH)</i>, anti-Müllerian hormone (<i>AMH)</i> and their receptors genes, gonadotropin-releasing hormone (<i>GnRH)</i>, estrogen, and progesterone receptors genes, the PCOS risk and the features of ovarian response to stimulation during ART cycles. The use of single nucleotide polymorphisms (SNPs) as prognostic markers of ART programs outcomes would provide a personalized approach to the drugs and doses choice for ovarian stimulation and significantly increase the chance of pregnancy.</p>","PeriodicalId":11332,"journal":{"name":"Drug metabolism and personalized therapy","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39682438","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Drug metabolism and personalized therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1